International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
The Growing Influence of the Institute of Clinical and… 11/21/2019
The Global Use of Medicine in 2019 and Outlook to 2023 01/29/2019
Medical Diagnostics: leveraging new opportunities from AI… 01/16/2020
Review of Influence: The Institute for Clinical and Economic Review 02/26/2019
Article Explores Wages, Salaries of HEOR Professionals,… 09/24/2019